Pro Medicus Valuation

Is PME undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PME when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PME (A$109.32) is trading above our estimate of fair value (A$40.54)

Significantly Below Fair Value: PME is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for PME?

Other financial metrics that can be useful for relative valuation.

PME key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue79.4x
Enterprise Value/EBITDA117.4x
PEG Ratio8.3x

Price to Book Ratio vs Peers

How does PME's PB Ratio compare to its peers?

The above table shows the PB ratio for PME vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average4.1x
VHT Volpara Health Technologies
6.7x115.0%AU$290.0m
4DX 4DMedical
2.6x45.6%AU$242.7m
CGS Cogstate
4x-9.4%AU$239.1m
M7T Mach7 Technologies
3.1x69.7%AU$171.3m
PME Pro Medicus
73.5x20.3%AU$11.4b

Price-To-Book vs Peers: PME is expensive based on its Price-To-Book Ratio (73.5x) compared to the peer average (4.1x).


Price to Earnings Ratio vs Industry

How does PME's PE Ratio compare vs other companies in the AU Healthcare Services Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a25.7%
n/an/an/a
No. of CompaniesPB048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a25.7%
n/an/an/a
No more companies

Price-To-Book vs Industry: PME is expensive based on its Price-To-Book Ratio (73.5x) compared to the Australian Healthcare Services industry average (3.1x).


Price to Book Ratio vs Fair Ratio

What is PME's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PME PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio73.5x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate PME's Price-To-Book Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PME forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$109.32
AU$95.57
-12.6%
29.7%AU$152.68AU$34.50n/a15
Apr ’25AU$103.73
AU$88.64
-14.5%
24.7%AU$120.00AU$34.50n/a14
Mar ’25AU$103.78
AU$88.64
-14.6%
24.7%AU$120.00AU$34.50n/a14
Feb ’25AU$100.53
AU$77.32
-23.1%
19.6%AU$100.00AU$34.50n/a12
Jan ’25AU$95.73
AU$78.14
-18.4%
19.0%AU$100.00AU$34.50n/a13
Dec ’24AU$87.91
AU$73.52
-16.4%
22.5%AU$90.00AU$34.50n/a13
Nov ’24AU$77.90
AU$71.99
-7.6%
22.0%AU$88.80AU$34.50n/a13
Oct ’24AU$83.67
AU$71.61
-14.4%
22.3%AU$88.80AU$33.50n/a13
Sep ’24AU$72.88
AU$67.29
-7.7%
21.2%AU$80.00AU$31.00n/a13
Aug ’24AU$69.26
AU$61.68
-10.9%
20.8%AU$79.33AU$30.00n/a13
Jul ’24AU$65.63
AU$59.24
-9.7%
20.2%AU$79.33AU$30.00n/a13
Jun ’24AU$61.55
AU$58.04
-5.7%
19.3%AU$71.00AU$30.00n/a12
May ’24AU$60.58
AU$59.41
-1.9%
17.8%AU$71.00AU$28.50AU$109.3211
Apr ’24AU$63.73
AU$59.41
-6.8%
17.8%AU$71.00AU$28.50AU$103.7311
Mar ’24AU$61.14
AU$56.65
-7.3%
21.2%AU$71.00AU$28.50AU$103.7812
Feb ’24AU$65.29
AU$54.03
-17.3%
20.4%AU$71.00AU$30.00AU$100.5312
Jan ’24AU$55.34
AU$53.76
-2.9%
20.3%AU$71.00AU$30.00AU$95.7312
Dec ’23AU$59.79
AU$52.90
-11.5%
19.6%AU$68.71AU$30.00AU$87.9111
Nov ’23AU$56.91
AU$52.72
-7.4%
20.5%AU$68.71AU$28.00AU$77.9011
Oct ’23AU$50.19
AU$52.72
+5.0%
20.5%AU$68.71AU$28.00AU$83.6711
Sep ’23AU$53.78
AU$52.10
-3.1%
19.2%AU$62.00AU$28.00AU$72.8811
Aug ’23AU$50.33
AU$50.27
-0.1%
18.5%AU$61.79AU$27.00AU$69.2610
Jul ’23AU$42.70
AU$50.52
+18.3%
19.7%AU$61.79AU$27.00AU$65.6310
Jun ’23AU$41.12
AU$54.11
+31.6%
10.0%AU$61.79AU$44.80AU$61.558
May ’23AU$47.66
AU$54.11
+13.5%
10.0%AU$61.79AU$44.80AU$60.588

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.